BALLARD PARTNERS

Lobbying for SHIONOGI, INC. · Pharmaceutical company

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · New Jersey · $50,000.00 income · posted Jul 18, 2026

Lobbying activity 1

Medical/Disease Research/Clinical Labs

Advocacy regarding biosecurity issues and treatments for rare disease.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem